slider
Virtual symposium by the iPVD Consortium: Microbes series – Co-Infection
Speaker:
// Hanan Yusuf Ahmed (University of Addis Ababa, Ethiopia)
Virtual symposium by the iPVD Consortium: Microbes series (Clinical Aspects) – HIV
Speaker:
// Nicola Petrosillo (University Hospital Campus Bio-Medico, Italy)
Virtual symposium by the iPVD Consortium: Microbes series – Bacteria
Speaker:
// Friedrich Thienemann (University of Cape Town, South Africa/University of Zurich, Switzerland)
Virtual symposium by the iPVD Consortium: Microbes series – microbiome & microbial metabolites
Speakers:
// Suellen D. Oliviera (University of Illinois at Chicago, USA) // Thenappan Thenappan (University of Minnesota, USA) // Imad Al Ghouleh (University of Pittsburgh, USA)
Virtual symposium by the iPVD Consortium: Infection series – fungi
Speakers:
// Sharilyn Almodovar (Texas Tech University, USA) // Alexandre Todorovic Fabro (University of São Paulo, Brazil)
Virtual symposium by the iPVD Consortium: Inflammation series – the role of Tregs
Speakers:
// Vinicio de Jesus Perez, Stanford University, USA
// Rajkumar Savai, Max Planck Institute for Heart and Lung Research, Germany
Virtual symposium by the iPVD Consortium: Inflammation series – inflamed lung
Speakers:
// Peter Nyasulu, University of the Witwatersrand, South Africa
// Rajkumar Savai, Max Planck Institute for Heart and Lung Research, Germany
Virtual symposium by the iPVD Consortium: Inflammation series – the endothelium
Speakers:
// Ghazwan Butrous, University of Kent, UK
// Suellen Darc Oliveira, University of Illinois at Chicago, USA
// Kewal Asosingh, Cleveland Clinic, USA
4th IPVD Symposium in Rio de Janeiro, Brazil: Embracing Heterogeneity
The 4th iPVD Symposium took place on January 29th during the 2025 PVRI Annual World Congress on PVD, held in Rio de Janeiro (Congress Program). Researchers and clinicians presented ground-breaking findings and had productive, lively discussions. Below are some of the highlights from our Symposium.
3rd IPVD Symposium in Athens, Greece
The 3rd iPVD symposium was held as a preconference meeting of the 15th PVRI Annual World Congress on PVD was held in Greece as a face-to-face meeting from 22-26 June 2022. Many thanks to our scientific organising committee for putting together a great programme.
2nd International Symposium of Infection and Pulmonary Vascular Diseases
The 2nd International Symposium of Infection and Pulmonary Vascular Diseases.
1st International Symposium on Infection and Pulmonary vascular Diseases Aswan, Egypt
First iPVD international meeting with multidisciplinary specialist on pulmonary vascular disease.
Pulmonary Hypertension Secondary to Fungal Infections: Underexplored Pathological Links
AbstractBackground/Objective: Pulmonary fungal infections are a significant diagnostic challenge, primarily affecting immunocompromised individuals, such as those with HIV, cancer, or organ transplants, and they often lead to substantial morbidity and mortality if untreated. These infections trigger acute inflammatory and immune responses, which may progress to chronic inflammation. This process involves myofibroblast recruitment, the deposition of extracellular matrix, and vascular remodeling, ultimately contributing to pulmonary hypertension. Despite its clinical relevance, pulmonary hypertension secondary to fungal infections remains under-recognized in practice and poorly studied in research. Results/Conclusion: This narrative mini-review explores three key mechanisms underlying vascular remodeling in this context: (1) endothelial […]
Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: Multilayered cross-talks in the setting of coinfections and comorbidities
AbstractThe Coronavirus Disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its sublineages pose a new challenge to healthcare systems worldwide due to its ability to efficiently spread in immunized populations and its resistance to currently available therapies. COVID-19, although targeting primarily the respiratory system, is also now well established that later affects every organ in the body. Most importantly, despite the available therapy and vaccine-elicited protection, the longterm consequences of viral infection in breakthrough and asymptomatic individuals are areas of concern. In the past two years, investigators accumulated evidence on how the virus triggers our […]
PulmonaryHypertension Day!
Let’s recognize patients, healthcare staff, researchers, and organizations working on this fatal disease. Celebrating today #PulmonaryHypertension Day! Let’s recognize patients, healthcare staff, researchers, and organizations working on this fatal disease. Together, we can raise awareness and advance research. #WorldPHDay2023 #WorldPHday @PVRI @PHAssociation